Tower Research Capital (TRC)’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59K | Buy |
14,652
+5,808
| +66% | +$23.4K | ﹤0.01% | 2830 |
|
|
2025
Q1 | $24.1K | Buy |
8,844
+5,969
| +208% | +$16.3K | ﹤0.01% | 2793 |
|
|
2024
Q4 | $12.2K | Sell |
2,875
-1,486
| -34% | -$6.32K | ﹤0.01% | 3638 |
|
|
2024
Q3 | $12.8K | Sell |
4,361
-3,873
| -47% | -$11.4K | ﹤0.01% | 3557 |
|
|
2024
Q2 | $28.7K | Buy |
8,234
+5,640
| +217% | +$19.6K | ﹤0.01% | 3516 |
|
|
2024
Q1 | $7.39K | Sell |
2,594
-6,921
| -73% | -$19.7K | ﹤0.01% | 4211 |
|
|
2023
Q4 | $33.6K | Buy |
9,515
+332
| +4% | +$1.17K | ﹤0.01% | 3356 |
|
|
2023
Q3 | $23.8K | Buy |
9,183
+7,683
| +512% | +$19.9K | ﹤0.01% | 3216 |
|
|
2023
Q2 | $5.91K | Sell |
1,500
-4,842
| -76% | -$19.1K | ﹤0.01% | 4750 |
|
|
2023
Q1 | $21K | Buy |
6,342
+5,865
| +1,230% | +$19.4K | ﹤0.01% | 3372 |
|
|
2022
Q4 | $2K | Sell |
477
-3,582
| -88% | -$15K | ﹤0.01% | 5332 |
|
|
2022
Q3 | $16K | Buy |
4,059
+325
| +9% | +$1.28K | ﹤0.01% | 4108 |
|
|
2022
Q2 | $17K | Buy |
3,734
+2,259
| +153% | +$10.3K | ﹤0.01% | 3943 |
|
|
2022
Q1 | $13K | Buy |
1,475
+1,454
| +6,924% | +$12.8K | ﹤0.01% | 3958 |
|
|
2021
Q4 | $0 | Sell |
21
-485
| -96% | – | ﹤0.01% | 6137 |
|
|
2021
Q3 | $5K | Buy |
+506
| New | +$5K | ﹤0.01% | 4828 |
|
|
2021
Q1 | – | Sell |
-6,834
| Closed | -$76K | – | 5401 |
|
|
2020
Q4 | $76K | Buy |
6,834
+3,986
| +140% | +$44.3K | ﹤0.01% | 2620 |
|
|
2020
Q3 | $28K | Buy |
2,848
+2,671
| +1,509% | +$26.3K | ﹤0.01% | 3747 |
|
|
2020
Q2 | $2K | Buy |
+177
| New | +$2K | ﹤0.01% | 4471 |
|